Crestline Management, LP Kala Pharmaceuticals, Inc. Transaction History

Crestline Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$9.54 - $13.87 $874,455 - $1.27 Million	-91,662 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.49 $400,901 - $527,201	30,143 Added 49.0%	91,662 $1.26 Million
Q1 2018 May 15, 2018	BUY	$12.26 - $18.98 $754,222 - $1.17 Million	61,519 New	61,519 $974,000
Q4 2017 Feb 14, 2018	SELL	$13.68 - $23.17 $531,933 - $900,942	-38,884 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$19.86 - $26.53 $772,236 - $1.03 Million	38,884	38,884 $888,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.81M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.